Primary sclerosing cholangitis, chronic ulcerative colitis, and bile duct dysplasia—Case presentation
K.V. Narayanan Menon – 18 October 2006
Abnormal liver enzymes 2‐3 months after liver transplantation in a patient with hepatitis C: Report of a case
Kymberly D.S. Watt – 18 October 2006
Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection
Anthony Jake Demetris – 18 October 2006 – Key Concepts: 1Recurrent primary sclerosing cholangitis (PSC) is extremely difficult, if not impossible, to distinguish from other causes of biliary strictures or sclerosing cholangitis in allografts using needle biopsy evaluation alone.
Early recurrence of hepatitis C virus infection after liver transplantation
Lydia M. Petrovic – 18 October 2006 – Key Concepts: 1Early recurrence of hepatitis C is universal.2Typical histopathologic features of hepatitis C virus (HCV) and acute allograft rejection (AAR) exist.3Early recurrent HCV may be differentiated from AAR.4Liver biopsy plays a role in diagnosing HCV and AAR.5Risk factors for recurrent HCV should be known.6The natural history of recurrent HCV should be known.7The future role of ancillary studies beyond liver biopsy is assessed. Liver Transpl 12:S32–S37, 2006. © 2006 AASLD.
Transplantation for cholangiocarcinoma
Debra L. Sudan – 18 October 2006
Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis
Laura E. Moreno Luna, Gregory J. Gores – 18 October 2006
Budd‐Chiari syndrome: Case report
Michael F. Sorrell – 18 October 2006
Abnormal liver function tests in the patient transplanted 3 years ago for alcoholic liver disease
Nathan M. Bass, Bernard C. Portmann, Michael R. Lucey – 18 October 2006